Skip to Main Content

Paper Details

Liquid biopsy epigenomic profiling for cancer subtyping.
Nat Med
5
2023
DNA methylation, advanced cancers, cancer, cancers, circulating, circulating tumor DNA, ctDNA, epigenomic, histone, patient, plasma
Author NameAffiliation
Sylvan C BacaDana-Farber Cancer Institute
Sylvan C BacaEli and Edythe L. Broad Institute
Sylvan C BacaCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Len TaingDana-Farber Cancer Institute
Len TaingCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Tim F GretenCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Keith L LigonDana-Farber Cancer Institute
Keith L LigonDana-Farber Cancer Institute
Mark M PomerantzDana-Farber Cancer Institute
Mark M PomerantzCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Mark M PomerantzDana-Farber Cancer Institute
Mark M PomerantzCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Sara M TolaneyDana-Farber Cancer Institute
Patrick Y WenCenter for Neuro-Oncology, Dana-Farber Cancer Institute
Patrick Y WenBrigham and Women's Hospital and Harvard Medical School
Toni K ChoueiriDana-Farber Cancer Institute
Matthew L FreedmanDana-Farber Cancer Institute
Matthew L FreedmanCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Matthew L FreedmanEli and Edythe L. Broad Institute
Matthew L FreedmanDana-Farber Cancer Institute
Matthew L FreedmanCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Matthew L FreedmanEli and Edythe L. Broad Institute
  • 1 - 22

Datasets